Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Cbdmd Inc (YCBD)

$3.18 0.00 (0.00%)

20:00 EST YCBD Stock Quote Delayed 15 Minutes

Volume:

Previous Close $3.18

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.)

Day's Range 3.18 - 3.18

52-Week Range 3.08 - 7.24

Dividend & Yield N/A (N/A)

YCBD Stock Predictions, Articles, and Cbdmd Inc News

From InvestorPlace
From the Web

7 Beverage Stocks to Stock Up On

By Josh Enomoto, InvestorPlace Contributor Nov 7, 2019

Thanks to a diverse consumer base with various needs, these top beverage stocks should be able to outperform the broader markets in the coming years.

30 Marijuana Stocks to Buy as the Future Turns Green

By Josh Enomoto, InvestorPlace Contributor Oct 30, 2019

Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.

10 Hot Pot Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor Oct 21, 2019

When pot stocks failed to live up to heightened expectations, investors panicked out of the sector. However, the selloff has probably gone on far too long, suggesting a possible comeback.

70 Biggest Movers From Yesterday

From Benzinga Nov 15, 2019

Gainers Sienna Biopharmaceuticals Inc (NASDAQ: SNNA) shares jumped 68.8% to close at $0.27 on Thursday after the company announced that Nasdaq granted the company's request...

48 Stocks Moving In Thursday's Mid-Day Session

From Benzinga Nov 14, 2019

Gainers Sienna Biopharmaceuticals Inc (NASDAQ: SNNA) shares climbed 93.5% to $0.3096 after the company announced that Nasdaq granted the company's request for continued...

Beneath the Q3 Setback Is an Opportunity for CRON Stock

From InvestorPlace Nov 13, 2019

While the Q3 report was disappointing for CRON stock, shares can still move higher as the company made a critical foothold in the U.S. CBD market.

3 Pros, 3 Cons for New Age Beverages Stock

From InvestorPlace Nov 12, 2019

NBEV stock has the potential to dominate the CBD-infused beverages market. But legal and competitive problems shouldn’t be ignored.

Cantor likes CV Sciences in premarket analyst action

From Seeking Alpha Nov 8, 2019

CdbMD (NYSEMKT:YCBD) initiated with Neutral rating and $3.40 (15% downside risk) price target at Cantor Fitzgerald.CV Sciences (OTCQB:CVSI) initiated with Overweight rating and $4.20 (177% upside) pri

7 Beverage Stocks to Stock up On

From InvestorPlace Nov 7, 2019

With sector companies offering cheap indulgences and meeting other specialized needs, these beverage stocks to buy provide significant upside potential.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!